With PR3 treatment, we show anatomical and functional preservation of the retina in RhoP23H mice, providing in vivo proof-of-concept of this novel therapeutic strategy for the treatment of RP. The gene discussed is PRTN3; the disease is retinitis pigmentosa 1.